Cargando…

Retrospective analysis of the clinical course of patients treated for polymyalgia

BACKGROUND: Polymyalgia rheumatica is a chronic inflammatory rheumatic condition, for which the mainstay of treatment is corticosteroids. Here, we review the clinical course of treated patients initially presenting with polymyalgic symptoms. METHODS: A retrospective audit was performed of patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Do-Nguyen, Dung, Inderjeeth, Charles A, Edelman, Jack, Cheah, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074791/
https://www.ncbi.nlm.nih.gov/pubmed/27790022
http://dx.doi.org/10.2147/OARRR.S38443
_version_ 1782461776048160768
author Do-Nguyen, Dung
Inderjeeth, Charles A
Edelman, Jack
Cheah, Patrick
author_facet Do-Nguyen, Dung
Inderjeeth, Charles A
Edelman, Jack
Cheah, Patrick
author_sort Do-Nguyen, Dung
collection PubMed
description BACKGROUND: Polymyalgia rheumatica is a chronic inflammatory rheumatic condition, for which the mainstay of treatment is corticosteroids. Here, we review the clinical course of treated patients initially presenting with polymyalgic symptoms. METHODS: A retrospective audit was performed of patients who presented with a possible diagnosis of polymyalgia rheumatica. Biochemical markers and prednisone doses were assessed at the initial review, at one month, and 3, 6, and 12 months later. RESULTS: A cohort of 135 patients was identified, comprising 91 females and 44 males of mean age 70.7 years. All patients were treated with oral prednisone at an initial mean dose of 21.3 mg. Mean baseline C-reactive protein level and erythrocyte sedimentation rate were 41.6 mg/L and 48.6 mm/hour, respectively. Following initiation of therapy, there was a dramatic and sustained decrease in both inflammatory markers. A clinical response was observed in 96.2% of patients, but remission was achieved in only 18.2%. Of those initially diagnosed with polymyalgia rheumatica, 24.8% were subsequently diagnosed with a different rheumatic condition. CONCLUSION: The excellent response rate to corticosteroid therapy is well established in the literature, but in this research, remission rates were comparatively low during the 12-month study period. The current value of disease-modifying antirheumatic drugs and biologic therapy appears uncertain, and further trials to establish their precise role would be beneficial. A large portion of patients presenting with polymyalgia were eventually diagnosed to have another rheumatic disease, thus reflecting the broad differential diagnosis of polymyalgia symptoms. Polymyalgia symptoms can occur in patients with polymyalgia rheumatica and other rheumatic conditions. This group has a good response to prednisone therapy, although remission at 12 months appears to be uncommon. The gold standard of treatment remains corticosteroid therapy.
format Online
Article
Text
id pubmed-5074791
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50747912016-10-27 Retrospective analysis of the clinical course of patients treated for polymyalgia Do-Nguyen, Dung Inderjeeth, Charles A Edelman, Jack Cheah, Patrick Open Access Rheumatol Review BACKGROUND: Polymyalgia rheumatica is a chronic inflammatory rheumatic condition, for which the mainstay of treatment is corticosteroids. Here, we review the clinical course of treated patients initially presenting with polymyalgic symptoms. METHODS: A retrospective audit was performed of patients who presented with a possible diagnosis of polymyalgia rheumatica. Biochemical markers and prednisone doses were assessed at the initial review, at one month, and 3, 6, and 12 months later. RESULTS: A cohort of 135 patients was identified, comprising 91 females and 44 males of mean age 70.7 years. All patients were treated with oral prednisone at an initial mean dose of 21.3 mg. Mean baseline C-reactive protein level and erythrocyte sedimentation rate were 41.6 mg/L and 48.6 mm/hour, respectively. Following initiation of therapy, there was a dramatic and sustained decrease in both inflammatory markers. A clinical response was observed in 96.2% of patients, but remission was achieved in only 18.2%. Of those initially diagnosed with polymyalgia rheumatica, 24.8% were subsequently diagnosed with a different rheumatic condition. CONCLUSION: The excellent response rate to corticosteroid therapy is well established in the literature, but in this research, remission rates were comparatively low during the 12-month study period. The current value of disease-modifying antirheumatic drugs and biologic therapy appears uncertain, and further trials to establish their precise role would be beneficial. A large portion of patients presenting with polymyalgia were eventually diagnosed to have another rheumatic disease, thus reflecting the broad differential diagnosis of polymyalgia symptoms. Polymyalgia symptoms can occur in patients with polymyalgia rheumatica and other rheumatic conditions. This group has a good response to prednisone therapy, although remission at 12 months appears to be uncommon. The gold standard of treatment remains corticosteroid therapy. Dove Medical Press 2013-04-24 /pmc/articles/PMC5074791/ /pubmed/27790022 http://dx.doi.org/10.2147/OARRR.S38443 Text en © 2013 Do-Nguyen et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Do-Nguyen, Dung
Inderjeeth, Charles A
Edelman, Jack
Cheah, Patrick
Retrospective analysis of the clinical course of patients treated for polymyalgia
title Retrospective analysis of the clinical course of patients treated for polymyalgia
title_full Retrospective analysis of the clinical course of patients treated for polymyalgia
title_fullStr Retrospective analysis of the clinical course of patients treated for polymyalgia
title_full_unstemmed Retrospective analysis of the clinical course of patients treated for polymyalgia
title_short Retrospective analysis of the clinical course of patients treated for polymyalgia
title_sort retrospective analysis of the clinical course of patients treated for polymyalgia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074791/
https://www.ncbi.nlm.nih.gov/pubmed/27790022
http://dx.doi.org/10.2147/OARRR.S38443
work_keys_str_mv AT donguyendung retrospectiveanalysisoftheclinicalcourseofpatientstreatedforpolymyalgia
AT inderjeethcharlesa retrospectiveanalysisoftheclinicalcourseofpatientstreatedforpolymyalgia
AT edelmanjack retrospectiveanalysisoftheclinicalcourseofpatientstreatedforpolymyalgia
AT cheahpatrick retrospectiveanalysisoftheclinicalcourseofpatientstreatedforpolymyalgia